The big question she concludes with is, “…will these treatments bring more pleasure to women or to the pharmaceutical industry?

ILLINOIS WAND By: Doug Wolfe Lincoln – A man abused by a priest at Holy Family Parish in Lincoln in the 1990’s will have his day in court.

Osphena isn’t estrogen; it just acts like one, and like estrogen-alone therapy, Osphena increases the risk of endometrial cancer.

Stroke and deep vein thrombosis are also risks of taking the drug, albeit low ones compared to estrogen-alone therapy, says the FDA.

Bishop Daniel Jenky has ousted several priests accused of abuse.

Last week the 3rd District Appellate Court held a lawsuit filed against the diocese was improperly dismissed on the grounds the statute of limitations expired in the 1990’s.

But how many women really need Osphena, and how safe is it?

For answers, looked to Newsweek’s Daily Beast, which has done some serious homework on the new drug.

These risks are detailed in a prominent black box warning on the drug.

Block also points out that some experts have questions about the clinical trials that led to Osphena’s approval: Block sees Osphena as the tip of an iceberg that may bring women testosterone gels and nasal sprays and antidepressants rebranded as libido enhancers.

Monsignor Norman Goodman was a pedophile that abused children at the church over several years.

A lawyer for one victim says the Diocese of Peoria turned a “blind eye” to that ongoing abuse.

“It was sexual assault, battery, that sort of thing,” attorney Jonathan Nessler told I-TEAM reporter Doug Wolfe at his Springfield office.